CA3220935A1 - Polytherapie utilisant des conjugues anticorps-medicament - Google Patents

Polytherapie utilisant des conjugues anticorps-medicament Download PDF

Info

Publication number
CA3220935A1
CA3220935A1 CA3220935A CA3220935A CA3220935A1 CA 3220935 A1 CA3220935 A1 CA 3220935A1 CA 3220935 A CA3220935 A CA 3220935A CA 3220935 A CA3220935 A CA 3220935A CA 3220935 A1 CA3220935 A1 CA 3220935A1
Authority
CA
Canada
Prior art keywords
antibody
adc
individual
treatment
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3220935A
Other languages
English (en)
Inventor
Patricius Hendrikus Cornelis VAN BERKEL
Francesca ZAMMARCHI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
MedImmune Ltd
Original Assignee
ADC Therapeutics SA
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA, MedImmune Ltd filed Critical ADC Therapeutics SA
Priority claimed from PCT/EP2022/067603 external-priority patent/WO2023274974A1/fr
Publication of CA3220935A1 publication Critical patent/CA3220935A1/fr
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente divulgation concerne des combinaisons de conjugués anticorps-médicament anti-CD19 et de conjugués anti-CD79b, et leur utilisation en thérapie, telles que le traitement de troubles prolifératifs.
CA3220935A 2021-06-29 2022-06-27 Polytherapie utilisant des conjugues anticorps-medicament Pending CA3220935A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2109373.7A GB202109373D0 (en) 2021-06-29 2021-06-29 Combination therapy
GB2109373.7 2021-06-29
PCT/EP2022/067603 WO2023274974A1 (fr) 2021-06-29 2022-06-27 Polythérapie utilisant des conjugués anticorps-médicament

Publications (1)

Publication Number Publication Date
CA3220935A1 true CA3220935A1 (fr) 2023-01-05

Family

ID=77179402

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3220935A Pending CA3220935A1 (fr) 2021-06-29 2022-06-27 Polytherapie utilisant des conjugues anticorps-medicament

Country Status (2)

Country Link
CA (1) CA3220935A1 (fr)
GB (1) GB202109373D0 (fr)

Also Published As

Publication number Publication date
GB202109373D0 (en) 2021-08-11

Similar Documents

Publication Publication Date Title
US11938192B2 (en) Dosage regimes for the administration of an anti-CD19 ADC
AU2018253951A1 (en) Combination therapy
WO2018193103A1 (fr) Polythérapie avec un conjugué anticorps anti-psma-médicament
CA3064681A1 (fr) Regimes posologiques pour l'administration d'un cam anti-cd25
WO2020249528A1 (fr) Polythérapie comprenant un conjugué médicament-anticorps anti-cd19 et un inhibiteur de pi3k ou un agent secondaire
EP3843748B1 (fr) Polythérapie
US20230132256A1 (en) Combination therapy
WO2020109251A1 (fr) Régime posologique
US20250352658A1 (en) Combination therapy using antibody-drug conjugates
CA3220935A1 (fr) Polytherapie utilisant des conjugues anticorps-medicament
EA050928B1 (ru) Комбинированная терапия с применением конъюгатов антитело-лекарственное средство
HK40101576A (zh) 使用抗体药物缀合物的组合疗法
CN117615791A (zh) 使用抗体药物缀合物的组合疗法
WO2022074033A1 (fr) Polythérapie
HK40028764A (en) Dosage regimes for the administration of an anti-cd19 adc
HK40028764B (en) Dosage regimes for the administration of an anti-cd19 adc

Legal Events

Date Code Title Description
W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20241125

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST TO REGISTER A DOCUMENT RECEIVED

Effective date: 20241125

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250529

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250529